호흡기 진단 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 검사 유형별, 질환 적응증별, 최종 용도별, 지역별, 경쟁별 세분화(2020-2030년)

The Global Respiratory Diagnostics Market, valued at USD 6.02 Billion in 2024, is projected to experience a CAGR of 7.10% to reach USD 9.09 Billion by 2030. The global respiratory diagnostics market encompasses a diverse range of medical tests, devices, assays, and services utilized for the identification, monitoring, and management of conditions affecting the respiratory system, including asthma, chronic obstructive pulmonary disease, and various infections. This market's expansion is primarily driven by the escalating worldwide prevalence of respiratory diseases, the growing elderly population exhibiting higher susceptibility to such conditions, and continuous technological advancements that enhance diagnostic precision and efficiency.

Key Market Drivers

The increasing prevalence of respiratory diseases represents a fundamental driver for the global respiratory diagnostics market, directly stimulating the demand for comprehensive diagnostic solutions. Conditions such as asthma, chronic obstructive pulmonary disease, and various infections continue to pose substantial public health challenges worldwide, necessitating timely and accurate detection for effective patient management. As populations grow and environmental factors contribute to disease incidence, the imperative for robust diagnostic capabilities intensifies.

Key Market Challenges

The significant capital investment needed for advanced diagnostic equipment directly impedes the growth of the Global Respiratory Diagnostics Market. Healthcare systems and providers, particularly within emerging economies, face considerable budget constraints that limit their capacity to acquire and upgrade such essential technology. This financial barrier often delays the adoption of new, more effective diagnostic solutions, thereby restricting overall market expansion.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning in diagnostics significantly reshapes the Global Respiratory Diagnostics Market by enhancing the precision and efficiency of disease detection. These advanced computational methods enable rapid analysis of complex data, identifying subtle patterns indicative of respiratory conditions earlier than traditional means.

Key Market Players

• Koninklijke Philips N.V
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA
• Siemens Healthineers AG
• PerkinElmer Inc.
• India Medtronic Private Limited
• Bio-Rad Laboratories, Inc.
• GE HealthCare Technologies Inc.

Report Scope:

In this report, the Global Respiratory Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Diagnostics Market, By Type:

• Instruments and Devices
• Assays & Reagents
• Services & Software

Respiratory Diagnostics Market, By Test Type:

• Mechanical Tests
• OSA Diagnostic Test
• Imaging Tests
• Traditional Diagnostic Test
• Molecular Diagnostic Tests

Respiratory Diagnostics Market, By Disease Indication:

• Tuberculosis
• Asthma
• Lung Cancer
• Chronic Obstructive Pulmonary Disease
• Others

Respiratory Diagnostics Market, By End-Use:

• Hospitals and Clinics
• Diagnostics Laboratory
• Others

Respiratory Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Respiratory Diagnostics Market.

Available Customizations:

Global Respiratory Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Instruments and Devices, Assays & Reagents, Services & Software)
  • 5.2.2. By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests)
  • 5.2.3. By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others)
  • 5.2.4. By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Respiratory Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Test Type
  • 6.2.3. By Disease Indication
  • 6.2.4. By End-Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Respiratory Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By Disease Indication
      • 6.3.1.2.4. By End-Use
  • 6.3.2. Canada Respiratory Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By Disease Indication
      • 6.3.2.2.4. By End-Use
  • 6.3.3. Mexico Respiratory Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By Disease Indication
      • 6.3.3.2.4. By End-Use

7. Europe Respiratory Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Test Type
  • 7.2.3. By Disease Indication
  • 7.2.4. By End-Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Respiratory Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By Disease Indication
      • 7.3.1.2.4. By End-Use
  • 7.3.2. France Respiratory Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By Disease Indication
      • 7.3.2.2.4. By End-Use
  • 7.3.3. United Kingdom Respiratory Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By Disease Indication
      • 7.3.3.2.4. By End-Use
  • 7.3.4. Italy Respiratory Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By Disease Indication
      • 7.3.4.2.4. By End-Use
  • 7.3.5. Spain Respiratory Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By Disease Indication
      • 7.3.5.2.4. By End-Use

8. Asia Pacific Respiratory Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Test Type
  • 8.2.3. By Disease Indication
  • 8.2.4. By End-Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Respiratory Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By Disease Indication
      • 8.3.1.2.4. By End-Use
  • 8.3.2. India Respiratory Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By Disease Indication
      • 8.3.2.2.4. By End-Use
  • 8.3.3. Japan Respiratory Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By Disease Indication
      • 8.3.3.2.4. By End-Use
  • 8.3.4. South Korea Respiratory Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Test Type
      • 8.3.4.2.3. By Disease Indication
      • 8.3.4.2.4. By End-Use
  • 8.3.5. Australia Respiratory Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Test Type
      • 8.3.5.2.3. By Disease Indication
      • 8.3.5.2.4. By End-Use

9. Middle East & Africa Respiratory Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Test Type
  • 9.2.3. By Disease Indication
  • 9.2.4. By End-Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Respiratory Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By Disease Indication
      • 9.3.1.2.4. By End-Use
  • 9.3.2. UAE Respiratory Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Disease Indication
      • 9.3.2.2.4. By End-Use
  • 9.3.3. South Africa Respiratory Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By Disease Indication
      • 9.3.3.2.4. By End-Use

10. South America Respiratory Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Test Type
  • 10.2.3. By Disease Indication
  • 10.2.4. By End-Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Respiratory Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By Disease Indication
      • 10.3.1.2.4. By End-Use
  • 10.3.2. Colombia Respiratory Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By Disease Indication
      • 10.3.2.2.4. By End-Use
  • 10.3.3. Argentina Respiratory Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By Disease Indication
      • 10.3.3.2.4. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Respiratory Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Koninklijke Philips N.V
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Abbott Laboratories Inc.
• 15.5. Dragerwerk AG & Co. KGaA
• 15.6. Siemens Healthineers AG
• 15.7. PerkinElmer Inc.
• 15.8. India Medtronic Private Limited
• 15.9. Bio-Rad Laboratories, Inc.
• 15.10. GE HealthCare Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer